{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:20Z","timestamp":1786119260774,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/meg.0b013e328317f1fe","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T04:46:50Z","timestamp":1257914810000},"page":"1400-1406","source":"Crossref","is-referenced-by-count":3,"title":["Factors influencing clinical course and histological findings in children with chronic hepatitis B"],"prefix":"10.1097","volume":"21","author":[{"given":"Iwona","family":"Mozer-Lisewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"S\u0142u\u017cewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kemnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Prusinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta","family":"Kowala-Piaskowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210207","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1440-1746.1998.tb00685.x","article-title":"Chronic hepatitis virus infection in children","volume":"13","author":"Chang","year":"1998","journal-title":"J Gastroeneterol Hepatol"},{"key":"R2-13-20210207","first-page":"1155","article-title":"Blind liver biopsy in children \u2013 diagnostic significance and complications in authors' own material","volume":"6","author":"Lebensztejn","year":"2000","journal-title":"Med Sci Monit"},{"key":"R3-13-20210207","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"R4-13-20210207","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading ad staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R5-13-20210207","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R6-13-20210207","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0168-8278(03)00005-9","article-title":"Scoring chronic hepatitis","volume":"38","author":"Desmet","year":"2003","journal-title":"J Hepatology"},{"key":"R7-13-20210207","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0168-8278(03)00139-9","article-title":"Natural history of hepatitis B","volume":"39","author":"Fattovich","year":"2003","journal-title":"J Hepatol"},{"key":"R8-13-20210207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.1840060203","article-title":"Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B","volume":"6","author":"Fattovich","year":"1986","journal-title":"Hepatology"},{"key":"R9-13-20210207","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(98)80002-0","article-title":"Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period","volume":"29","author":"Bortolotti","year":"1998","journal-title":"J Hepatol"},{"key":"R10-13-20210207","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"R11-13-20210207","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0016-5085(90)90972-4","article-title":"Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood","volume":"99","author":"Bortolotti","year":"1990","journal-title":"Gastroenterology"},{"key":"R12-13-20210207","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/hep.1840130218","article-title":"Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood","volume":"13","author":"Chang","year":"1991","journal-title":"Hepatology"},{"key":"R13-13-20210207","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"R14-13-20210207","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(05)80425-8","article-title":"Antiviral therapy of chronic hepatitis B: past, present and future","volume":"17","author":"Perrillo","year":"1993","journal-title":"J Hepatol"},{"key":"R15-13-20210207","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2165\/00003495-200565110-00001","article-title":"Drugs in development for hepatitis B","volume":"65","author":"Buti","year":"2005","journal-title":"Drugs"},{"key":"R16-13-20210207","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa012452","article-title":"Clinical trial of lamivudine in children with chronic hepatitis B","volume":"346","author":"Jonas","year":"2002","journal-title":"N Engl J Med"},{"key":"R17-13-20210207","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00008480-199910000-00003","article-title":"Update on prevention and treatment of viral hepatitis in children","volume":"11","author":"Sokal","year":"1999","journal-title":"Curr Opin Pediatr"},{"key":"R18-13-20210207","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2001-12-0192","article-title":"Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C","volume":"99","author":"Minola","year":"2002","journal-title":"Blood"},{"key":"R19-13-20210207","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0016-5085(98)70318-X","article-title":"Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial","volume":"114","author":"Sokal","year":"1998","journal-title":"Gastroenterology"},{"key":"R20-13-20210207","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.46.5.715","article-title":"Long term effect of alpha interferon in children with chronic hepatitis B","volume":"46","author":"Bortolotti","year":"2000","journal-title":"Gut"},{"key":"R21-13-20210207","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1086\/521864","article-title":"Long-term outcome in children with chronic hepatitis B: a 24-year observation period","volume":"45","author":"Iorio","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R22-13-20210207","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.21077","article-title":"Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study","volume":"43","author":"Bortolotti","year":"2006","journal-title":"Hepatology"},{"key":"R23-13-20210207","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.21811","article-title":"Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"R24-13-20210207","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.21585","article-title":"Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels","volume":"45","author":"Lin","year":"2007","journal-title":"Hepatology"},{"key":"R25-13-20210207","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005176-200002000-00019","article-title":"Long- term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood","volume":"30","author":"Fujisawa","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042737-200912000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:41Z","timestamp":1786039661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042737-200912000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0b013e328317f1fe","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}